Has psychedelic research reached a tipping point?
In 2021, psychedelic medicines moved from the frontiers of scientific research to the front pages of newspapers worldwide.
This was driven by a growing body of research and the results of groundbreaking clinical trials. Studies have demonstrated the potential for psychedelic medicines to treat a wide range of illnesses, where currently available treatments have proven ineffective, which has garnered the support of healthcare providers, patients and the public.
The Psychedelics as Medicine Report: Third Edition revealed two-thirds of Europeans and North Americans support the legalisation of psychedelic-assisted therapy, with jurisdictions enacting legislation to facilitate its adoption. Six states in the United States have decriminalised psychedelic medicines, with 20 loosening regulations to support research into their efficacy.Read More